The Corneal Transplant Follow-up Study has followed 2311 penetrating k
eratoplasties for up to 450 days after transplant, A total of 207 fail
ures were observed, including 65 classical rejections and 35 endotheli
al decompensations, At 12 months, graft survival was 89%, and survival
free from rejection was 87%. For surviving grafts, risk of failure re
duced from 4.8% in the first 75 days and stabilized after 5 months at
1.2% in each 75-day interval. Risk of rejection initially followed a s
imilar pattern, but then increased after 12 months. Multifactorial ana
lyses accounted for differences in recipient characteristics and inter
relationships of donor factors. Donor age, sex, cause of death, and me
thod of corneal storage were not found to influence significantly eith
er time to graft failure or time to first rejection. Grafts in prospec
tively tissue-typed donor-recipient pairs were generally considered be
fore surgery to be at increased risk of either graft failure or reject
ion. With due allowance, increasing risk of rejection was associated w
ith increasing numbers of mismatches at HLA-A and HLA-B broad antigens
. The opposite was true at HLA-DR broad antigens, where increased risk
of rejection was observed with no mismatches.